Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Amortization of Deferred Charges (2020 - 2024)

Seres Therapeutics (MCRB) has disclosed Amortization of Deferred Charges for 5 consecutive years, with $463000.0 as the latest value for Q3 2024.

  • Quarterly Amortization of Deferred Charges rose 17.81% to $463000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $463000.0 through Jun 2025, down 73.57% year-over-year, with the annual reading at $1.4 million for FY2024, 24.06% up from the prior year.
  • Amortization of Deferred Charges hit $463000.0 in Q3 2024 for Seres Therapeutics, down from $485000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $2.2 million in Q4 2021 to a low of $118000.0 in Q1 2021.
  • Historically, Amortization of Deferred Charges has averaged $375312.5 across 5 years, with a median of $208500.0 in 2020.
  • Biggest five-year swings in Amortization of Deferred Charges: skyrocketed 872.07% in 2021 and later crashed 92.96% in 2022.
  • Year by year, Amortization of Deferred Charges stood at $222000.0 in 2020, then surged by 872.07% to $2.2 million in 2021, then plummeted by 92.96% to $152000.0 in 2022, then soared by 169.08% to $409000.0 in 2023, then increased by 13.2% to $463000.0 in 2024.
  • Business Quant data shows Amortization of Deferred Charges for MCRB at $463000.0 in Q3 2024, $485000.0 in Q2 2024, and $465000.0 in Q1 2024.